The Journal of Urology
Volume 172, Issue 4, Supplement , Pages 1590-1594 , October 2004

PREVENTION OF RENAL FIBROSIS BY SPIRONOLACTONE IN MICE WITH COMPLETE UNILATERAL URETERAL OBSTRUCTION

REFERENCES 

  1. Remuzzi G , Bertani T . Pathophysiology of progressive nephropathies . N Engl J Med . 1998;339:1448
  2. Ketteler M , Noble NA , Border WA . Transforming growth factor-β and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis . Ann Rev Physiol . 1995;57:279
  3. Jafar TH , Schmid CH , Landa M , Giatris I , Toto R , Remuzzi G , et al.   Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient level data . Ann Intern Med . 2001;135:73
  4. Delyani JA . Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology . Kidney Int . 2000;57:1408
  5. Fivush BA , Jabs K , Neu AM , Sullivan EK , Feld L , Kohaut E , et al.   Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS . Pediatr Nephrol . 1998;12:328
  6. Huang A , Palmer LS , Hom D , Valderrama E , Trachtman H . The role of nitric oxide in obstructive uropathy . J Urol . 2000;163:1276
  7. Chang B , Mathew R , Palmer LS , Valderrama E , Trachtman H . Nitric oxide in obstructive uropathy: role of endothelial nitric oxide synthase . J Urol . 2002;168:1801
  8. Ishidoya S , Morrissey J , McCracken R , Klahr S . Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive uropathy . Kidney Int . 1996;49:1110
  9. Warshaw BL , Edelbrock HH , Ettenger RB , Malekzadeh MH , Pennisi AJ , Uittenbogaart CH , et al.   Progression to end-stage renal disease in children with obstructive uropathy . J Pediatr . 1982;100:183
  10. Chevalier RL . Molecular and cellular pathophysiology of obstructive nephropathy . Pediatr Nephrol . 1999;13:612
  11. Kagami S , Border WA , Miller DE , Noble NA . Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells . J Clin Invest . 1994;93:2431
  12. Yamamoto T , Noble NA , Miller DE , Border WA . Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis . Kidney Int . 1994;45:916
  13. Sharma VK , Bologa RM , Xu GP , Li B , Mouradian J , Wang J , et al.   Intragraft TGF-β1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy . Kidney Int . 1996;49:1297
  14. Lijnen P , Petrov V . Induction of cardiac fibrosis by aldosterone . J Mol Cell Cardiol . 2000;32:865
  15. Young MJ , Funder J . The renin-angiotensin system in experimental mineralocorticoid-salt-induced cardiac fibrosis . Am J Physiol . 1996;271:E883
  16. Pitt B , Zannad F , Remme WJ , Cody R , Castaigne A , Perez A , et al.   The effect of spironolactone on morbidity and mortality in patients with severe heart failure . N Engl J Med . 1999;341:709
  17. Chrysostomou A , Becker G . Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease . N Engl J Med . 2001;345:925
  18. Kinter M , Wolstenholme JT , Thornhill BA , Newton EA , McCormick ML , Chevalier RL . Unilateral ureteral obstruction impairs renal antioxidant enzyme activation during sodium depletion . Kidney Int . 1999;55:1327
  19. Laverman GD , Navis G , Henning RH , De Jong PE , De Zeeeuw D . Dual renin-angiotensin system blockade at optimal doses for proteinuria . Kidney Int . 2002;62:1020
  20. Agarwal R , Siva S , Dunn SR , Sharma K . Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels . Am J Kidney Dis . 2002;39:486

 Papers Presented at Annual Meeting of the Section on Urology, American Academy of Pediatrics

PII: S0022-5347(05)61315-8

doi: 10.1097/01.ju.0000140445.82949.54

The Journal of Urology
Volume 172, Issue 4, Supplement , Pages 1590-1594 , October 2004

Article Tools

* Image Usage & Resolution